Industry News
Pharmaceutical Industry News
England’s drug price watchdog rejects Orchard’s groundbreaking gene therapy after first round of talks
England's drug price watchdog rejects Orchard's groundbreaking gene therapy after first round of talks kdunleavy Fri, 07/09/2021 - 11:07
What heart safety concern? Doctors like Incyte’s eczema cream despite potential JAK warning: analyst
What heart safety concern? Doctors like Incyte's eczema cream despite potential JAK warning: analyst aliu Fri, 07/09/2021 - 10:30
Philip Morris strikes $1.45B deal for Vectura, sending another would-be buyer back to the drawing board
Philip Morris strikes $1.45B deal for Vectura, sending another would-be buyer back to the drawing board fkansteiner Fri, 07/09/2021 - 09:38
Philip Morris strikes $1.45B deal for Vectura, sending another would-be buyer back to the drawing board
Philip Morris strikes $1.45B deal for Vectura, sending another would-be buyer back to the drawing board fkansteiner Fri, 07/09/2021 - 09:38
Moving the vaccination needle: Study examines behavioral tactics that work—and don’t
Moving the vaccination needle: Study examines behavioral tactics that work—and don’t bbulik Fri, 07/09/2021 - 09:17
Fierce Pharma Asia—Ex-Genentech staffers’ IP theft; Lundbeck’s Alzheimer’s deal; China’s oncology R&D rule
Fierce Pharma Asia—Ex-Genentech staffers' IP theft; Lundbeck's Alzheimer's deal; China's oncology R&D rule aliu Fri, 07/09/2021 - 07:36
Johnson & Johnson’s Stelara posts positive 3-year data in ulcerative colitis as competition heats up
Johnson & Johnson's Stelara posts positive 3-year data in ulcerative colitis as competition heats up kdunleavy Fri, 07/09/2021 - 06:52
Johnson & Johnson’s Stelara posts positive 3-year data in ulcerative colitis as competition heats up
Johnson & Johnson's Stelara posts positive 3-year data in ulcerative colitis as competition heats up kdunleavy Fri, 07/09/2021 - 06:52
Citing the Delta Variant, Pfizer Will Pursue Booster Shots and a New Vaccine
Scientists were critical of the announcement, pointing to evidence that the current two-dose regimen is powerfully effective against the coronavirus.
Pfizer plots course for COVID-19 booster, but the CDC isn’t sure ‘whether or when’ follow-up shots will be needed
Pfizer plots course for COVID-19 booster, but the CDC isn't sure 'whether or when' follow-up shots will be needed fkansteiner Thu, 07/08/2021 - 20:56
Coronavirus Briefing: What Happened Today
What we know about the Lambda variant, first discovered in Peru.
A week after losing CEO to Moderna, Ogilvy Health taps new global chief from parent WPP
A week after losing CEO to Moderna, Ogilvy Health taps new global chief from parent WPP bbulik Thu, 07/08/2021 - 18:01
15 States Reach a Deal With Purdue Pharma Over Opioids
The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.
Merck scores a win in bellwether Zostavax case, but nearly 2,000 remain
Merck scores a win in bellwether Zostavax case, but nearly 2,000 remain kdunleavy Thu, 07/08/2021 - 15:21
OxyContin maker Purdue wins 15 states’ support in controversial $4B bankruptcy plan
OxyContin maker Purdue wins 15 states' support in controversial $4B bankruptcy plan fkansteiner Thu, 07/08/2021 - 11:33
With plans for a massive plant in China, small Chicago biotech Sparx could be the talk of the town in Yangzhou
With plans for a massive plant in China, small Chicago biotech Sparx could be the talk of the town in Yangzhou kdunleavy Thu, 07/08/2021 - 10:14
With plans for a massive plant in China, small Chicago biotech Sparx could be the talk of the town in Yangzhou
With plans for a massive plant in China, small Chicago biotech Sparx could be the talk of the town in Yangzhou kdunleavy Thu, 07/08/2021 - 10:14
GlaxoSmithKline to close Memphis consumer health plant, putting 150 jobs on the chopping block
GlaxoSmithKline to close Memphis consumer health plant, putting 150 jobs on the chopping block fkansteiner Thu, 07/08/2021 - 09:30
GlaxoSmithKline to close Memphis consumer health plant, putting 150 jobs on the chopping block
GlaxoSmithKline to close Memphis consumer health plant, putting 150 jobs on the chopping block fkansteiner Thu, 07/08/2021 - 09:30
Biogen, FDA walk back controversial Aduhelm label after weeks of fierce criticism
Biogen, FDA walk back controversial Aduhelm label after weeks of fierce criticism nhigginsdunn Thu, 07/08/2021 - 08:54